Cell Therapy for Cardiovascular Diseases

Cell therapy has emerged as a promising approach for treating cardiovascular diseases (CVDs), offering potential for repairing damaged heart tissue, improving cardiac function, and enhancing patient outcomes. Cardiovascular diseases, including heart failure, myocardial infarction (heart attack), and ischemic heart disease, are leading causes of morbidity and mortality worldwide. Cell therapy aims to address these conditions by using various types of cells to regenerate heart tissue and restore its function. MSCs are multipotent cells derived from bone marrow, adipose tissue, or umbilical cord tissue. They have anti-inflammatory and immunomodulatory properties and can differentiate into various cell types, including cardiomyocytes (heart muscle cells) and vascular endothelial cells. MSCs have been shown to improve cardiac function and reduce scar tissue after myocardial infarction.

    Cell Therapy for Cardiovascular Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in